Product Information
CLINDAMYCIN HCL 300 MG CAPSULE is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1724 per EA under NDC 59762501002. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
300 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762501002
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLINDAMYCIN HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA050162On Market Since
5/22/1970
Pharmacological Classes
Price Statistics
The NADAC for CLINDAMYCIN HCL 300 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 28.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1724 per EA |
|---|---|
| All-time high | $0.3115 (Nov 13, 2019) |
| All-time low | $0.1674 (Nov 20, 2024) |
| 52-week high | $0.1947 |
| 52-week low | $0.1724 |
| Median price | $0.2493 |
| Average price | $0.2404 |
| Largest weekly change | +33.6% (Aug 21, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLINDAMYCIN HCL 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN HCL 300 MG CAPSULE, manufactured by Mylan Pharmaceuticals Inc., is $0.1724 per EA (NDC 59762501002), effective Jun 24, 2026.
How has the price of CLINDAMYCIN HCL 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CLINDAMYCIN HCL 300 MG CAPSULE has declined 28.7%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLINDAMYCIN HCL 300 MG CAPSULE?
Since Nov 28, 2013, the NADAC for CLINDAMYCIN HCL 300 MG CAPSULE has ranged from a low of $0.1674 (Nov 20, 2024) to a high of $0.3115 (Nov 13, 2019), with a median of $0.2493 per EA.
Are there cheaper alternatives to CLINDAMYCIN HCL 300 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CLINDAMYCIN HCL 300 MG CAPSULE, but none are currently priced below it.
Who manufactures CLINDAMYCIN HCL 300 MG CAPSULE?
CLINDAMYCIN HCL 300 MG CAPSULE (NDC 59762501002) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification